RESPONSE TO REGULATORY STRINGENCY: THE CASE OF ANTIPSYCHOTIC MEDICATION USE IN NURSING HOMES

被引:29
作者
Bowblis, John R. [1 ,2 ]
Crystal, Stephen [3 ]
Intrator, Orna [4 ,5 ]
Lucas, Judith A. [3 ]
机构
[1] Miami Univ, Dept Econ, Farmer Sch Business 3044, Oxford, OH 45056 USA
[2] Miami Univ, Scripps Gerontol Ctr, Oxford, OH 45056 USA
[3] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA
[4] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA
[5] Providence VA Med Ctr, Providence, RI USA
基金
美国医疗保健研究与质量局;
关键词
regulation; nursing homes; antipsychotics; deficiencies; STAFFING LEVELS; DRUG-USE; QUALITY; RISK; PAYMENT; COST; HYPERLIPIDEMIA; REIMBURSEMENT; DEFICIENCIES; ENFORCEMENT;
D O I
10.1002/hec.1775
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper studies the impact of regulatory stringency, as measured by the statewide deficiency citation rate over the past year, on the quality of care provided in a national sample of nursing homes from 2000 to 2005. The quality measure used is the proportion of residents who are using antipsychotic medication. Although the changing case-mix of nursing home residents accounts for some of the increase in the use of antipsychotics, we find that the use of antipsychotics by nursing homes is responsive to state regulatory enforcement in a manner consistent with the multitasking incentive problem. Specifically, the effect of the regulations is dependent on the degree of complementarity between the regulatory deficiency and the use of antipsychotics. Copyright (c) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:977 / 993
页数:17
相关论文
共 47 条
[1]  
[Anonymous], 020000490 OEI US DEP
[2]   Unequally spaced panel data regressions with AR(1) disturbances [J].
Baltagi, BH ;
Wu, PX .
ECONOMETRIC THEORY, 1999, 15 (06) :814-823
[3]  
Banaszak-Holl J., 2002, MANAG DECIS ECON, V23, P261, DOI [10.1002/mde.1065, DOI 10.1002/MDE.1065]
[4]   OWNERSHIP CONVERSION AND CLOSURE IN THE NURSING HOME INDUSTRY [J].
Bowblis, John R. .
HEALTH ECONOMICS, 2011, 20 (06) :631-644
[5]   The quality of antipsychotic drug prescribing in nursing homes [J].
Briesacher, BA ;
Limcangco, R ;
Simoni-Wastila, L ;
Doshi, JA ;
Levens, SR ;
Shea, DG ;
Stuart, B .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1280-1285
[6]   Nursing home deficiency citations for medication use [J].
Castle, Nicholas G. ;
Engberg, John B. .
JOURNAL OF APPLIED GERONTOLOGY, 2007, 26 (02) :208-232
[7]   Factor substitution in nursing homes [J].
Cawley, J ;
Grabowski, DC ;
Hirth, RA .
JOURNAL OF HEALTH ECONOMICS, 2006, 25 (02) :234-247
[8]  
Centers for Medicare and Medicaid Services (CMS), 2004, STAT OP MAN
[9]  
Centers for Medicare and Medicaid Services [CMS], 2006, STAT OP MAN
[10]  
Cohen M.A., 1996, Journal of Health Economics, V15, P23